In Vivo Pharma Intelligence | RNA Medicines: Advancements Leading To Investments
12/01/2022
12/01/2022
Amanda Micklus
12/01/22
Executive Summary
Improvements in generating, purifying, and delivering RNA material, as well as addressing challenges with degradation by enzymes, have made the RNA class more attractive to drug developers.